Oncology Clinical Pharmacist - Management Drug Therapy - Full-Time - Day

Remote Work Capable

Essential Functions:

• Evaluates appropriateness of drug therapy for patients with specialty conditions referred to the WellSpan Management of Drug Therapy (MDT) Clinic (e.g., rheumatology, dermatology, endocrinology).
• Adjusts drug therapy and order laboratory tests or other diagnostic tests necessary in the management of drug therapy under Collaborative Practice Agreement (CPA) or written protocol in accordance with state law.
• Monitors treatment efficacy, therapeutic outcomes, safety parameters, and adherence for patients receiving biologics and other specialty agents.
• Identifies and resolves drug therapy problems throughout the course of medication therapy.
• Provides patient education and counseling regarding disease state, medication use, side effects, and lifestyle modifications.
• Communicates and documents therapy changes and updates with providers in accordance with written protocol in the electronic health record (EHR).
• Collaborates with providers, nurses, and other care team members in the different specialty practices or pharmacy to coordinate care.
• Monitors adherence and persistence for patients receiving specialty medications; implement adherence strategies when gaps are identified.
• Ensures compliance with accreditation standards (URAC, ACHC, or NCQA if applicable), and organizational policies.
• Participates in quality improvement, program development, accreditation compliance activities, and payor contracting guidelines.

Common Expectations:

• Stays current with evidence-based practice, specialty guidelines, and regulatory updates through continuing education, seminars, workshops, and professional affiliations.
• Provides outstanding service to all customers; fosters teamwork; and practices fiscal responsibility through improvement and innovation.
• Demonstrates a commitment to patient, visitor and staff by: complying with all applicable safety regulations; learning the impact of medical errors and methodology that will lead to reduction of errors; reporting actual and potential errors, as well as hazardous conditions; identifying opportunities to standardize processes and "error proof" systems that will lead to increased safety; and participating in safety education programs and root cause analyses as required.